Patent Assignment
Reel/Frame 061321/0991
Assignment of Assignor's Interest
Recorded: 2022-10-05
Pages: 6
Assignee
INCYTE CORPORATION
1801 AUGUSTINE CUT-OFF, WILMINGTON, DELAWARE, 19803
Covered Property
(1)
Combination Therapy Comprising an Fgfr Inhibitor and a Nectin-4 Targeting Agent
Patent:
12,065,494 →
Application:
17/717,464 →
Publication:
US 2022/0324986
PCT:
PCT/US2022/024210 ↗